We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Phio Pharmaceuticals (PHIO - Free Report) : This company which is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform, has seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.
Flex LNG (FLNG - Free Report) : This shipping company which is focused on transportation of liquefied natural gas, has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
Bridgewater Bancshares (BWB - Free Report) : This bank holding company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.
Alerus Financial (ALRS - Free Report) : This financial services company, which offers banking, retirement and benefit services, wealth management and mortgage to businesses and consumers, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 day.
Halozyme Therapeutics (HALO - Free Report) : This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.
Image: Bigstock
New Strong Buy Stocks for May 28th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Phio Pharmaceuticals (PHIO - Free Report) : This company which is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform, has seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.
Phio Pharmaceuticals Corp. Price and Consensus
Phio Pharmaceuticals Corp. price-consensus-chart | Phio Pharmaceuticals Corp. Quote
Flex LNG (FLNG - Free Report) : This shipping company which is focused on transportation of liquefied natural gas, has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
Flex LNG Ltd. Price and Consensus
Flex LNG Ltd. price-consensus-chart | Flex LNG Ltd. Quote
Bridgewater Bancshares (BWB - Free Report) : This bank holding company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.
Bridgewater Bancshares, Inc. Price and Consensus
Bridgewater Bancshares, Inc. price-consensus-chart | Bridgewater Bancshares, Inc. Quote
Alerus Financial (ALRS - Free Report) : This financial services company, which offers banking, retirement and benefit services, wealth management and mortgage to businesses and consumers, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 day.
Alerus Financial Price and Consensus
Alerus Financial price-consensus-chart | Alerus Financial Quote
Halozyme Therapeutics (HALO - Free Report) : This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.
Halozyme Therapeutics, Inc. Price and Consensus
Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.